University Hospital for Tumours of Zagreb: Difference between revisions

From Beacon
 
(100 intermediate revisions by 7 users not shown)
Line 1: Line 1:
The University Hospital for Tumors of Zagreb is a tumor clinic that constantly monitors and implements new methods of tumor treatment, and carries out multiple research and teaching projects. It has been part of the Sestre Milosrdnice University Hospital Centre since 2010.
<span style="display:none">forresearchers</span>
<span style="display:none">forpatients</span>
<span style="display:none">forproviders</span>
<span style="display:none">forpolicymakers</span>
<span style="display:none">croatiacountry</span>
<span style="display:none">hospital</span>
<span style="display:none">isCancerCenter</span>
[https://wiki.beaconcancer.org/index.php?title=Cancer_Centers Go back to Cancer Centers list.]
{{#set:
[[hasCoordinates::45.813039, 15.9433842]]
}}
== [[hasClinicalTrial::University Hospital for Tumours of Zagreb Trials|Trials]] ==
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">
</div>


[[Croatia|See other cancer centers in Croatia.]]
== [[hasExperts::Experts (University Hospital for Tumours of Zagreb)|Experts]] ==
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">
</div>


== [[Trials]] ==
== Learning Resources ==
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">


'''[https://clinicaltrials.gov/ct2/show/NCT03782207?recrs=abdfm&cond=Cancer&locn=Clinical+Hospital+Center+Sestre+Milosrdnice%3B+Clinic+for+tumors&cntry=HR&draw=2&rank=2 A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice (IMreal)]'''
=== [[hasEvent::Events:_Courses,_events_and_symposiums_(University_Hospital_for_Tumours_of_Zagreb)|Events: Courses, events and symposiums]] ===


'''Summary:''' This is a non-interventional, multi-country, multi-centre, multiple cohort prospective study, with retrospective collection of prior medical/treatment history data from medical records, designed to assess the real-world outcomes and safety of atezolizumab for indications in the existing label in the real world setting of routine clinical practice.
=== [[hasLearningResource::Resource:_Library_of_the_University_Hospital_for_Tumours_(University_Hospital_for_Tumours_of_Zagreb)|Resource: Library of the University Hospital for Tumours]] ===


'''Sponsor, manager, or home institution:''' Hoffmann-La Roche
=== [[hasTraining::Training:_Specialist_Training_(University_Hospital_for_Tumours_of_Zagreb)|Training: Specialist Training]] ===


'''Intervention/Treatment:''' Drug: Atezolizumab
</div>


'''Number of patients:''' 3400 participants
== [[hasHospitalCapacityInfo::Novel Therapies and Diagnostic Methods (University Hospital for Tumours of Zagreb)|Novel Therapies and Diagnostic Methods]] ==


'''Beginning Date:''' December 20, 2018
== Cancer-related Patient Associations and Resources ==
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">


'''Last Update:''' December 20, 2022
=== [[hasPatientResource::Resource: Patient Guides (University Hospital for Tumours of Zagreb)|Resource: Patient Guides]] ===


'''Recruitment Status:''' Recruiting.
=== [[hasPatientResource::Facility: Religious services (University Hospital for Tumours of Zagreb)|Facility: Religious services]] ===


'''Cancer areas of interest:''' Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Hepatocellular Carcinoma
=== [[hasPatientResource::Facility: Exhibitions and concerts (University Hospital for Tumours of Zagreb)|Facility: Exhibitions and concerts]] ===
</div>


'''[https://clinicaltrials.gov/ct2/show/NCT04740918?recrs=abdfm&cond=Cancer&locn=University+Hospital+for+Tumors&cntry=HR&draw=1&rank=2 A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC) (KATE3)]'''
== [[isEHDENParticipant::EHDEN Participation (University Hospital for Tumours of Zagreb)|EHDEN Participation]] ==
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">
</div>


'''Summary:''' This study will evaluate the efficacy, safety and patient-reported outcomes of trastuzumab emtansine plus atezolizumab compared with trastuzumab emtansine plus placebo in participants with HER2-positive and PD-L1-positive LABC or MBC.Participants must have progressed either during or after prior trastuzumab- (+/- pertuzumab) and taxane-based therapy for LABC/MBC; or during (or within 6 months after completing) trastuzumab- (+/-pertuzumab) and taxane-based therapy in the neoadjuvant and/or adjuvant setting.
__NOTOC__
 
<span style="display:none">hasCoordinates::45.813039, 15.9433842</span>
'''Sponsor, manager, or home institution:''' Hoffmann-La Roche
<span style="display:none">hasClinicalTrial::University Hospital for Tumours of Zagreb Trials|Trials</span>
 
<span style="display:none">hasExperts::Experts (University Hospital for Tumours of Zagreb)|Experts</span>
'''Intervention/Treatment:'''
<span style="display:none">hasEvent::Events:_Courses,_events_and_symposiums_(University_Hospital_for_Tumours_of_Zagreb)|Events: Courses, events and symposiums</span>
Drug: Trastuzumab Emtansine;
<span style="display:none">hasLearningResource::Resource:_Library_of_the_University_Hospital_for_Tumours_(University_Hospital_for_Tumours_of_Zagreb)|Resource: Library of the University Hospital for Tumours</span>
Drug: Atezolizumab;
<span style="display:none">hasHospitalCapacityInfo::Novel Therapies and Diagnostic Methods (University Hospital for Tumours of Zagreb)|Novel Therapies and Diagnostic Methods</span>
Other: Placebo
<span style="display:none">hasPatientResource::Resource: Patient Guides (University Hospital for Tumours of Zagreb)|Resource: Patient Guides</span>
 
<span style="display:none">hasPatientResource::Facility: Religious services (University Hospital for Tumours of Zagreb)|Facility: Religious services</span>
'''Number of patients:''' 320 participants
<span style="display:none">hasPatientResource::Facility: Exhibitions and concerts (University Hospital for Tumours of Zagreb)|Facility: Exhibitions and concerts</span>
 
<span style="display:none">isEHDENParticipant::EHDEN Participation (University Hospital for Tumours of Zagreb)|EHDEN Participation</span>
'''Beginning Date:''' February 5, 2021
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span>
 
<span style="display:none">hasCancerType::C00-C97: All cancer types</span>
'''Last Update:''' December 14, 2022
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
 
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span>
'''Recruitment Status:''' Recruiting
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
 
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
'''Cancer areas of interest:''' Metastatic Breast Cancer
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
 
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
== [[Experts]] ==
<span style="display:none">hasCancerType::C50: Breast cancer</span>
 
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
====Department of Anesthesiology, Reanimatology and Intensive Treatment====
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
 
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
'''Procedures:''' abdominal, gynecological, head and neck oncologic surgeries along with oncoplastic and reconstructive surgery.
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
 
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
'''Contact''': Information can be found [https://www.kbcsm.hr/klinike/klinika-za-tumore/anesteziologija-reanimacija-i-intezivno-lijecenje/ here]
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
 
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
====Department of Head and Neck Surgery====
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
 
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
'''Procedures:''' Works on squamous cell carcinomas of the upper aerodigestive system, salivary gland, skin cancers, melanomas of the head, neck and thyroid surgical treatments and plastic-reconstructive surgery combined with radiotherapy, chemotherapy and rehabilitation.
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
 
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
'''Contact''': Information can be found [https://www.kbcsm.hr/klinike/klinika-za-tumore/zavod-za-kirusku-onkologiju/ here]
<span style="display:none">hasCancerType::unknown</span>
 
====Department of Gynecological-Oncological Surgery====
 
'''Procedures:''' Acts on prevention and early diagnosis of gynecological tumors using modern medical equipment, performs consults, local radiation therapy, and surgeries with endoscopic, vaginal and laparotomic approaches.
 
'''Contact''': Information can be found [https://www.kbcsm.hr/klinike/klinika-za-tumore/zavod-za-kirusku-onkologiju/odjel-za-ginekolosko-onkolosku-kirurgiju/ here]
 
====Department of Oncological Pathology and Clinical Cytology====
'''Procedures:''' Works with the methods of biopsy, immunohistochemical markers, chromogenic in situ hybridization (CISH), silver-stained in situ hybridization (SISH), and PCR analysis to examinate the received samples. Also acts on emergency cytology.
 
'''Contact''': Information can be found [https://www.kbcsm.hr/klinike/klinika-za-tumore/onkoloska-patologija/ here]
 
====Department of Internal Oncology====
'''Procedures:''' unknown
 
'''Contact''': Information can be found [https://www.kbcsm.hr/zavod-za-internisticku-onkologiju/ here]
 
====Department of Radiotherapy and Oncology====
'''Procedures: unknown'''
 
'''Contact''': Information can be found [https://www.kbcsm.hr/zavod-za-radioterapiju-i-onkologiju/ here]
 
====Institute for Oncoplastic and Reconstructive Surgery====
'''Procedures:''' unknown
 
'''Contact''': Information can be found [https://www.kbcsm.hr/zavod-za-onkoplastiku-i-rekonstruktivnu-kirurgiju/ here]
 
====Department of Oncoplasty====
'''Procedures:''' Diagnosis by USV of the breast and abdomen, mammography, MRI, cytopuncture, biopsy, X-ray processing, and sentinel node biopsy or axillary lymph node dissection. Cancer systemic treatments used are chemotherapy, immunotherapy, hormone therapy and radiation. Performs radical, reconstructive and sparing surgical procedures involved in surgical removal of tumors and assymmetry correction. Also acts on treatment of melanoma and soft tissue sarcomas
 
'''Contact''': Information can be found [https://www.kbcsm.hr/klinike/klinika-za-tumore/zavod-za-kirusku-onkologiju/odjel-za-onkoplastiku/ here]
 
== [[Learning Resources]] ==
 
=== Library of the University Hospital for Tumors ===
 
'''Content Type:''' Library containing publications from the field of oncology and other biomedical subjects such as surgery, radiology, anesthesia, otorhinolaryngology, internal medicine, radiotherapy, etc. The library can also be used to search medical databases, bibliometric services and certificates, and other information. Librarians can help with instructions on how to find relevant literature. There are currently about 1,722 printed books and about 14,000 volumes of magazines (130 titles).
 
'''Target Audience:''' Anyone in the region can access the library and create an account. The content is more relevant to providers and researchers.
 
'''Open Data Access:''' [http://library.foi.hr/lib/index.php?page=&B=1409&H=&o=&K=&V=&D=&lok=&ogr=&upit= Library can be accessed here.]
<!--
=== Other Learning Materials ===
 
== [[Novel Therapies and Diagnostic Methods]] ==
 
== [[Cancer-related Patient Associations]] ==
 
=== Example ===
 
'''Primary Purpose:'''
 
'''Members:'''
-->

Latest revision as of 16:39, 22 January 2026

forresearchers forpatients forproviders forpolicymakers croatiacountry hospital isCancerCenter Go back to Cancer Centers list.

Trials[edit | edit source]

Experts[edit | edit source]

Learning Resources[edit | edit source]

Events: Courses, events and symposiums[edit | edit source]

Resource: Library of the University Hospital for Tumours[edit | edit source]

Training: Specialist Training[edit | edit source]

Novel Therapies and Diagnostic Methods[edit | edit source]

Cancer-related Patient Associations and Resources[edit | edit source]

Resource: Patient Guides[edit | edit source]

Facility: Religious services[edit | edit source]

Facility: Exhibitions and concerts[edit | edit source]

EHDEN Participation[edit | edit source]


hasCoordinates::45.813039, 15.9433842 hasClinicalTrial::University Hospital for Tumours of Zagreb Trials|Trials hasExperts::Experts (University Hospital for Tumours of Zagreb)|Experts hasEvent::Events:_Courses,_events_and_symposiums_(University_Hospital_for_Tumours_of_Zagreb)|Events: Courses, events and symposiums hasLearningResource::Resource:_Library_of_the_University_Hospital_for_Tumours_(University_Hospital_for_Tumours_of_Zagreb)|Resource: Library of the University Hospital for Tumours hasHospitalCapacityInfo::Novel Therapies and Diagnostic Methods (University Hospital for Tumours of Zagreb)|Novel Therapies and Diagnostic Methods hasPatientResource::Resource: Patient Guides (University Hospital for Tumours of Zagreb)|Resource: Patient Guides hasPatientResource::Facility: Religious services (University Hospital for Tumours of Zagreb)|Facility: Religious services hasPatientResource::Facility: Exhibitions and concerts (University Hospital for Tumours of Zagreb)|Facility: Exhibitions and concerts isEHDENParticipant::EHDEN Participation (University Hospital for Tumours of Zagreb)|EHDEN Participation hasCancerType::C00-D48: All neoplasms hasCancerType::C00-C97: All cancer types hasCancerType::C00-C14: Mouth/throat cancers hasCancerType::C15-C26: Digestive system cancers hasCancerType::C30-C39: Lung/chest cancers hasCancerType::C40-C41: Bone cancers hasCancerType::C43-C44: Skin cancers/melanoma hasCancerType::C45-C49: Soft tissue cancer hasCancerType::C50: Breast cancer hasCancerType::C51-C58: Female genitalia cancers hasCancerType::C60-C63: Male genitalia cancer hasCancerType::C64-C68: Urinary system cancers hasCancerType::C69-C72: Eye and brain cancer hasCancerType::C73-C75: Thyroid and other gland cancers hasCancerType::C76-C80: Cancers of unknown or unspecified areas hasCancerType::C81-C96: Cancers of the blood and immune system hasCancerType::C97-C97: Cancers in multiple locations from the start hasCancerType::D00-D09: Early-stage cancers not yet spread hasCancerType::D10-D36: Benign tumour hasCancerType::D37-D48: Growths of uncertain nature hasCancerType::unknown

Retrieved from "https://wiki.beaconcancer.org/index.php?title=University_Hospital_for_Tumours_of_Zagreb&oldid=36205"
Powered by MediaWiki
Powered by Semantic MediaWiki